Materialise (NASDAQ:MTLS – Get Free Report) released its quarterly earnings results on Thursday. The software maker reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.02, FiscalAI reports. Materialise had a net margin of 4.85% and a return on equity of 5.22%. The company had revenue of $79.97 million for the quarter, compared to analyst estimates of $78.23 million.
Here are the key takeaways from Materialise’s conference call:
- Q2 revenue grew 8% year over year to €70.1 million, led by Medical growth of more than 12% and Manufacturing growth of nearly 7%. Adjusted EBIT increased to €3.9 million, with the margin expanding to 5.5%.
- Management reaffirmed full-year 2026 revenue guidance of €273 million–€283 million and raised adjusted EBIT guidance to €12 million–€14 million, citing cost discipline and stronger execution.
- Software revenue declined 3% in Q2 to €9.6 million as industrial customers remained cautious and sales cycles lengthened; Medical software was also pressured by reduced U.S. research grants and reimbursement-related caution in orthopedics.
- Materialise reported a stronger financial position, with €74.2 million in net cash, €11.4 million of first-half free cash flow, and €5.2 million invested in share buybacks. Manufacturing profitability also improved substantially, with quarterly adjusted EBITDA loss narrowing to €0.3 million from €4.8 million.
- The company launched CO-AM Pro ahead of schedule and began early-adopter programs for CO-AM NPI and Enterprise, which management views as future software growth drivers, particularly as aerospace and defense customers scale additive manufacturing.
Materialise Stock Down 5.4%
Shares of MTLS stock opened at $7.02 on Friday. Materialise has a 12 month low of $4.78 and a 12 month high of $7.50. The company has a quick ratio of 2.24, a current ratio of 2.42 and a debt-to-equity ratio of 0.18. The firm has a market cap of $414.67 million, a PE ratio of 26.00 and a beta of 1.34. The stock has a 50 day moving average of $6.76 and a 200-day moving average of $6.00.
Analyst Upgrades and Downgrades
Get Our Latest Analysis on MTLS
Hedge Funds Weigh In On Materialise
Institutional investors and hedge funds have recently bought and sold shares of the stock. Quinn Opportunity Partners LLC bought a new stake in Materialise in the 4th quarter valued at $391,000. Goldman Sachs Group Inc. bought a new position in shares of Materialise during the 4th quarter worth about $179,000. Credit Agricole S A acquired a new position in shares of Materialise during the third quarter valued at about $2,166,000. Banque Transatlantique SA acquired a new position in shares of Materialise during the third quarter valued at about $86,000. Finally, Walleye Capital LLC bought a new stake in shares of Materialise in the second quarter valued at about $150,000. Institutional investors own 19.30% of the company’s stock.
Key Materialise News
Here are the key news stories impacting Materialise this week:
- Positive Sentiment: Share buyback to resume: Materialise said it will restart its American Depositary Share repurchase program after renewing the required authorization. Buybacks can support per-share value and signal management confidence in the stock. Materialise to Resume Share Buyback Program After Renewal of Authorization
- Positive Sentiment: Quarterly earnings beat estimates: Materialise reported adjusted EPS of $0.07 versus the $0.05 consensus forecast, while revenue also exceeded expectations. The result indicates continued operating improvement and may support investor sentiment. Materialise Q2 2026 Earnings Results
- Positive Sentiment: Growth and guidance maintained: Second-quarter revenue rose 8.1% year over year to approximately €70.1 million, with adjusted EBITDA also increasing. Management reaffirmed 2026 revenue guidance of €273 million to €283 million and provided an adjusted EBIT outlook of $12 million to $14 million. Materialise 2026 EBIT Outlook and Revenue Guidance
- Positive Sentiment: Medical and aerospace momentum: Materialise highlighted growth in medical software and aerospace, alongside a broader digital-transformation strategy. These areas could improve the company’s longer-term mix and profitability. Materialise Half-Year 2026 Report
- Neutral Sentiment: Execution remains important: The portfolio refocus and digital-transformation plans could create future growth, but investors will likely watch whether these initiatives translate into stronger margins. Materialise’s reported net margin remains relatively low at 3.77%. Materialise Strong Leadership and Digital Transformation Fuel Growth
About Materialise
Materialise NV is a Belgium-based company specializing in 3D printing software and additive manufacturing services. Through its dual focus on software and printing, the company addresses a wide range of industries, including automotive, aerospace, consumer goods, and healthcare. Materialise’s offerings span from design and simulation tools to end-to-end production, delivering both standardized and highly customized parts across polymer and metal platforms.
On the software side, Materialise develops a suite of proprietary applications—such as Magics for data preparation, Mimics for medical image processing and patient-specific modeling, and Streamics for production workflow management.
Recommended Stories
- Five stocks we like better than Materialise
- MarketBeat Week in Review – 08/24 – 08/28
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
Receive News & Ratings for Materialise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Materialise and related companies with MarketBeat.com's FREE daily email newsletter.
